Company

AstraZeneca (LSE:AZN)

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.

About AZN

Related Articles

Investing Articles

1 FTSE 100 stock I wouldn’t miss buying in November

This FTSE 100 stock has seen a decline in share price in recent months. But that might be about to…

Read more »

Investing Articles

2 FTSE 100 dividend stocks I’d aim to never sell

I wouldn't try to hold all my investments forever, but these two FTSE 100 dividend stocks both have many qualities…

Read more »

Syringe and vial on blue background
Investing Articles

AstraZeneca (LON:AZN) makes progress in the fight against liver cancer

The AstraZeneca (LON:AZN) share price idles despite the firm reporting positive results from its liver cancer clinical trials.

Read more »

Investing Articles

These 2 FTSE 100 stocks are beaten down bargains in my opinion!

This Fool identifies two FTSE 100 picks he believes are beaten down stocks that could be potential bargains with upside…

Read more »

Investing Articles

Why I’d buy AstraZeneca shares today

AstraZeneca shares have rallied since the vaccine rollout. As we move into a post-pandemic world, I discuss why AstraZeneca piques…

Read more »

Investing Articles

3 FTSE 100 stocks to buy for the long term

These FTSE 100 stocks are among the biggest gainers today, but this Fool reckons that their long-term prospects are good…

Read more »

Investing Articles

2 UK shares to buy now for growth

From his list of top UK shares to buy now for his portfolio, our writer considers two firms whose growth…

Read more »

Investing Articles

AstraZeneca (AZN) shares gain on acquisition news

AstraZeneca (LON: AZN) expands its presence in rare disease development with a further acquisition, sending its shares higher.

Read more »

Syringe and vial on blue background
Investing Articles

The Oxford Biomedica share price has doubled since signing its Covid-19 vaccine deal. Can the momentum continue?

Oxford Biomedica’s share price is soaring. But is this simply the hype of its Covid-19 vaccine deal? Megan Boxall examines…

Read more »

Investing Articles

2 FTSE 100 stocks to buy in a market crash

As the FTSE 100 continues to fall, Charlie Keough looks at two stocks he would add to his portfolio should…

Read more »